Welcure Drugs & Pharmaceuticals Ltd — Updates, 08-07-2025: Company Update

Welcure Drugs & Pharmaceuticals has announced a board meeting to review its financial results for the quarter and half-year. The company has completed export-sourcing orders totaling ₹299.91 crore across seven international customers. Acting as a procurement agent, Welcure earns a fixed 5% commission on these orders, with buyers directly settling goods costs. All transactions were fee-based and involved no related parties. The company remains debt-free, and commission income will be recognized upon receipt. This update confirms the completion of consignments and the company’s ongoing commitment to timely disclosures.